Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · IEX Real-Time Price · USD
7.13
+0.05 (0.71%)
At close: Apr 30, 2024, 4:00 PM
7.04
-0.09 (-1.26%)
After-hours: Apr 30, 2024, 6:02 PM EDT
Fulcrum Therapeutics Revenue
In the year 2023, Fulcrum Therapeutics had annual revenue of $2.81M, a decrease of -55.77%. Revenue in the quarter ending December 31, 2023 was $871.00K with 27.15% year-over-year growth.
Revenue (ttm)
$2.81M
Revenue Growth
-55.77%
P/S Ratio
157.43
Revenue / Employee
$36,908
Employees
76
Market Cap
441.60M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.81M | -3.54M | -55.77% |
Dec 31, 2022 | 6.34M | -12.82M | -66.90% |
Dec 31, 2021 | 19.16M | 10.34M | 117.19% |
Dec 31, 2020 | 8.82M | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Community Health Systems | 12.52B |
Aveanna Healthcare Holdings | 1.90B |
MultiPlan | 961.52M |
Travere Therapeutics | 145.24M |
Editas Medicine | 78.12M |
Fate Therapeutics | 63.53M |
C4 Therapeutics | 20.76M |
Taysha Gene Therapies | 15.45M |
FULC News
- 5 weeks ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023 - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8:00 a.m. ET - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 6 months ago - Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences - GlobeNewsWire
- 6 months ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023 - GlobeNewsWire